Protocol No.: A032201

Title
Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE
Principal Investigator
Kolodney, Joanna
Phase
III
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
Contacts
Sabrina Rexroad, RN
Research Nurse
Valli White, RN
Research Nurse
Phone: +1 304-264-1220
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000
Jill Stone, LPN
Research Specialist
Phone: +1 304-634-4417

View on ClinicalTrials.gov